The control and manipulation of angiogenesis in the primate corpus luteum

of Thesis The corpus luteum is formed from the preovulatory follicle after ovulation and its main function is the secretion of progesterone which is essential for the establishment of pregnancy. Growth of the corpus luteum is associated with extensive vascular remodelling, so that by the mid-luteal phase every steroidogenic cell is adjacent to a capillary for optimal synthesis and secretion of progesterone. In the non-fertile cycle luteal vascular regression takes place and progesterone production falls. If conception occurs the corpus luteum is rescued and continues to produce progesterone. The corpus luteum provides a unique example of tightly controlled physiological angiogenesis. Little is known about the effect of inhibition of physiological angiogenesis that occurs in female reproductive tissues. Elucidation of the process of luteal angiogenesis may provide new insights into tumour therapy and treatment of infertility, and offer a novel approach to contraception research. Previous research focused on angiogenesis in the non-primate ovary but the mechanisms that regulate luteal function in primates are markedly different, therefore the marmoset monkey, supplemented with archived human corpora lutea, was used for the research described in this thesis. Angiogenesis is a dynamic process of endothelial cell proliferation and capillary tubule formation, controlled primarily by vascular endothelial cell growth factor (VEGF); and capillary stabilisation by the association of pericytes. In vivo luteal angiogenesis was assessed by measuring these parameters in luteal sections by quantitative immunocytochemistry. It was established that 1) quantification of cell proliferation by bromodeoxyuridine administration to label DNA during the S phase of the cell cycle was a robust and reproducible technique; 2) over 80% of proliferating cells in marmoset corpora lutea were endothelial cells; and 3) quantification of these parameters in one luteal section reflected the angiogenic activity of the whole corpus luteum. In the primate, early luteal development was associated with intense angiogenesis, expression of VEGF and the growth of a stable microvascular network. In the mid-luteal mature gland angiogenesis was ongoing but at a reduced level, VEGF expression remained high and a full microvascular network had been established containing both stable microvessels and small immature capillaries, optimal for maximal progesterone production and secretion. In the late corpus luteum, endothelial cell proliferation and VEGF expression declined, there were signs of immature vessel regression and progesterone levels decreased markedly. Human chorionic gonadotropin administered to women from the mid-luteal phase to rescue the corpus luteum, was associated with increased angiogenesis and VEGF production, and stabilisation of newly formed vessels.

[1]  N. Ling,et al.  Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: implications for a role of heparinase-like enzymes in the neovascular response. , 1987, Biochemical and biophysical research communications.

[2]  A. Zeleznik,et al.  Progesterone does not inhibit gonadotropin-induced follicular maturation in the female rhesus monkey (Macaca mulatta). , 1980, Endocrinology.

[3]  M. Janicek,et al.  Tumor angiogenesis as a prognostic factor in ovarian carcinoma , 1997, Cancer.

[4]  A. Zeleznik,et al.  Ovarian responses in macaques to pulsatile infusion of follicle-stimulating hormone (FSH) and luteinizing hormone: increased sensitivity of the maturing follicle to FSH. , 1986, Endocrinology.

[5]  S. Steinberg,et al.  Tumor angiogenesis in advanced stage ovarian carcinoma. , 1995, The American journal of pathology.

[6]  F. Teasdale Numerical density of nuclei in the sheep placenta , 1976, The Anatomical record.

[7]  J. Strauss,et al.  Stimulation of progesterone synthesis in luteinized human granulosa cells by human chorionic gonadotropin and 8-bromo-adenosine 3',5'-monophosphate: the effect of low density lipoprotein. , 1984, The Journal of clinical endocrinology and metabolism.

[8]  S. Killilea,et al.  Mitogenic factors of corpora lutea. , 1994, Progress in growth factor research.

[9]  P. Hornsby,et al.  The role of lipid peroxidation and biological antioxidants in the function of the adrenal cortex. Part 1: A background review , 1983, Molecular and Cellular Endocrinology.

[10]  D. Baird,et al.  Mediation of gonadotrophin‐stimulated growth and differentiation of human granulosa cells by adenosine‐3′,5′‐monophosphate: one molecule, two messages , 1992, Clinical endocrinology.

[11]  Pamela F. Jones,et al.  Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning , 1996, Cell.

[12]  R. Goldenberg,et al.  Ovarian morphology in women with anosmia and hypogonadotropic hypogonadism. , 1976, American journal of obstetrics and gynecology.

[13]  Sandra R. Smith,et al.  An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Flanagan,et al.  Heterodimers of Placenta Growth Factor/Vascular Endothelial Growth Factor , 1996, The Journal of Biological Chemistry.

[15]  J. Kraehenbuhl,et al.  Localization of intracellular antigens by immunoelectron microscopy. , 1974, International review of experimental pathology.

[16]  D. Dierschke,et al.  Functional luteolysis in the rhesus monkey; the role of estrogen. , 1973, Endocrinology.

[17]  H. Fraser,et al.  Initiation of high dose gonadotrophin-releasing hormone antagonist treatment during the late follicular phase in the macaque abolishes luteal function irrespective of effects upon the luteinizing hormone surge. , 1997, Human reproduction.

[18]  A. Zeleznik,et al.  Gonadotropin-binding sites in the rhesus monkey ovary: role of the vasculature in the selective distribution of human chorionic gonadotropin to the preovulatory follicle. , 1981, Endocrinology.

[19]  W. Chamley,et al.  Changes in small blood vessels during cyclical luteal regression in sheep. , 1977, Biology of reproduction.

[20]  H. Tamura,et al.  Angiogenesis and its hormonal control in the corpus luteum of the pregnant rat. , 1987, Biology of reproduction.

[21]  A. Hirshfield Continuous [3H] thymidine infusion: a method for the study of follicular dynamics. , 1984, Biology of reproduction.

[22]  D. Charnock-Jones,et al.  Localization of VEGF and expression of its receptors flt and KDR in human placenta throughout pregnancy. , 1996, Human reproduction.

[23]  A. L. Goodman,et al.  Regulation of folliculogenesis in the cycling rhesus monkey: selection of the dominant follicle. , 1977, Endocrinology.

[24]  H. Fraser,et al.  Inhibition of early luteal angiogenesis by gonadotropin-releasing hormone antagonist treatment in the primate. , 2000, The Journal of clinical endocrinology and metabolism.

[25]  H. Fraser,et al.  GnRH receptor mRNA expression by in-situ hybridization in the primate pituitary and ovary. , 1996, Molecular human reproduction.

[26]  D. Redmer,et al.  Angiogenesis in the ovary. , 1996, Reviews of reproduction.

[27]  D. Baird,et al.  Differential regulation of cholesterol side-chain cleavage (P450scc) and aromatase (P450arom) enzyme mRNA expression by gonadotrophins and cyclic AMP in human granulosa cells. , 1994, Journal of molecular endocrinology.

[28]  R. Nicosia,et al.  Rat aortic smooth muscle cells become pericytes during angiogenesis in vitro. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[29]  J. McGeachie,et al.  Angiogenesis in the developing corpus luteum of pregnant rats: A stereologic and autoradiographic study , 1988, The Anatomical record.

[30]  T J Poole,et al.  Vasculogenesis and angiogenesis: two distinct morphogenetic mechanisms establish embryonic vascular pattern. , 1989, The Journal of experimental zoology.

[31]  J. Cameron,et al.  Gonadotropin receptors of the primate corpus luteum. I. Characterization of 125I-labeled human luteinizing hormone and human chorionic gonadotropin binding to luteal membranes from the rhesus monkey. , 1982, Endocrinology.

[32]  F. Gaytán,et al.  Proliferative activity in the different ovarian compartments in cycling rats estimated by the 5-bromodeoxyuridine technique. , 1996, Biology of reproduction.

[33]  C. Heldin,et al.  B-type receptor for platelet-derived growth factor mediates a chemotactic response by means of ligand-induced activation of the receptor protein-tyrosine kinase. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[34]  E. Lenton,et al.  The endocrinology of conception cycles and implantation in women. , 1988, Journal of reproduction and fertility. Supplement.

[35]  S. L. Marcus,et al.  Functional activity of the corpus luteum following hysterectomy. , 1970, The Journal of clinical endocrinology and metabolism.

[36]  H. Fraser,et al.  Luteal regression in the primate: different forms of cell death during naturaland gonadotropin-releasing hormone antagonist or prostaglandin analogue-induced luteolysis. , 1999, Biology of reproduction.

[37]  F. Khan-dawood,et al.  Expression of gap junction protein connexin-43 in the human and baboon (Papio anubis) corpus luteum. , 1996, The Journal of clinical endocrinology and metabolism.

[38]  L. Speroff,et al.  Prostaglandin F-2 induced steroidogenesis and luteolysis in the primate corpus luteum. , 1973, The Journal of clinical endocrinology and metabolism.

[39]  J. Zheng,et al.  Initial characterization of endothelial mitogens produced by bovine corpora lutea from the estrous cycle. , 1993, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[40]  J. Tilly Apoptosis and the ovary: a fashionable trend or food for thought? , 1997, Fertility and sterility.

[41]  H. Moukadiri,et al.  Characterization of the receptor to vasculotropin on bovine adrenal cortex-derived capillary endothelial cells. , 1990, The Journal of biological chemistry.

[42]  D. Gospodarowicz,et al.  Characterization of the receptors for vascular endothelial growth factor. , 1990, The Journal of biological chemistry.

[43]  R. Stouffer,et al.  Isolation and culture of microvascular endothelial cells from the primate corpus luteum. , 1996, Biology of reproduction.

[44]  G. Gray,et al.  Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. , 1991, Cancer research.

[45]  G. Niswender,et al.  Mechanisms of luteolysis in domestic livestock. , 1988, Domestic animal endocrinology.

[46]  D. Goeddel,et al.  Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.

[47]  Pamela F. Jones,et al.  Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis , 1996, Cell.

[48]  J. Hodges,et al.  Comparison of the luteolytic action of gonadotrophin-releasing hormone antagonist and cloprostenol, and the ability of human chorionic gonadotrophin and melatonin to override their luteolytic effects in the marmoset monkey. , 1991, The Journal of endocrinology.

[49]  V. Lenaerts,et al.  Antarelix (EP 24332) a novel water soluble LHRH antagonist. , 1993, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[50]  H. Granger,et al.  Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[51]  D. de Ziegler,et al.  Role of estradiol in the rise in follicle-stimulating hormone levels during the luteal-follicular transition. , 1993, The Journal of clinical endocrinology and metabolism.

[52]  A. Gougeon,et al.  Evolution of the diameters of the largest healthy and atretic follicles during the human menstrual cycle. , 1983, Journal of reproduction and fertility.

[53]  G. Yancopoulos,et al.  Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. , 1999, Genes & development.

[54]  Lars Holmgren,et al.  Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression , 1995, Nature Medicine.

[55]  J. Winer,et al.  Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. , 1994, The Journal of biological chemistry.

[56]  D. Baird,et al.  Concentration of oestrogens and androgens in human ovarian venous plasma and follicular fluid throughout the menstrual cycle. , 1976, The Journal of endocrinology.

[57]  M. E. Simpson,et al.  Postnatal development of the ovary in Homo sapiens and Macaca mulatta, and induction of ovulation in the macaque, , 1973 .

[58]  M. Skinner,et al.  3 – Growth Factor-Mediated Cell–Cell Interactions in the Ovary , 1994 .

[59]  J. Rossant,et al.  Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium , 1995, Nature.

[60]  A HENRIQUES FURTADO,et al.  [Early pregnancy]. , 1947, Revista de ginecologia e d'obstetricia.

[61]  F. Khan-dawood,et al.  Baboon corpus luteum: presence of oxytocin receptors. , 1993, Biology of reproduction.

[62]  S. Fox,et al.  Association of tumor angiogenesis with bone marrow micrometastases in breast cancer patients. , 1997, Journal of the National Cancer Institute.

[63]  G. Yancopoulos,et al.  New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF , 1999, Oncogene.

[64]  Kenneth J. Hillan,et al.  Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene , 1996, Nature.

[65]  J. Cornette,et al.  Vascular control of luteal steroidogenesis. , 1970, Journal of reproduction and fertility. Supplement.

[66]  J. Juengel,et al.  Mechanisms controlling the function and life span of the corpus luteum. , 2000, Physiological reviews.

[67]  J. Juengel,et al.  Protein kinase C second messenger system mediates the antisteroidogenic effects of prostaglandin F2 alpha in the ovine corpus luteum in vivo. , 1994, Biology of reproduction.

[68]  G. Aguilera,et al.  Localization of insulin-like growth factor (IGF-I) and IGF-I receptor expression in human corpora lutea: role on estradiol secretion**Supported by FONDECYT 1931041, Santiago, Chile. , 1996 .

[69]  L. Espey Ovulation as an inflammatory reaction--a hypothesis. , 1980, Biology of reproduction.

[70]  H. Peters,et al.  Follicular growth: the basic event in the mouse and human ovary. , 1975, Journal of reproduction and fertility.

[71]  L. Cantley,et al.  Vascular Dysmorphogenesis Caused by an Activating Mutation in the Receptor Tyrosine Kinase TIE2 , 1996, Cell.

[72]  R. Meidan,et al.  Regulation of endothelin-1 expression in the bovine corpus luteum: elevation by prostaglandin F 2 alpha. , 1996, Endocrinology.

[73]  N. Dekel,et al.  8 – Molecular Mechanisms in Ovulation , 1994 .

[74]  L. Reynolds Utero-ovarian interactions during early pregnancy: role of conceptus-induced vasodilation. , 1986, Journal of animal science.

[75]  A. Gougeon Dynamics of follicular growth in the human: a model from preliminary results. , 1986, Human reproduction.

[76]  Sabita Roy,et al.  Targeting the tumor vasculature: Inhibition of tumor growth by a vascular endothelial growth factor‐toxin conjugate , 1997, International journal of cancer.

[77]  G. D. Phillips,et al.  Vascular endothelial growth factor (rhVEGF165) stimulates direct angiogenesis in the rabbit cornea. , 1994, In vivo.

[78]  L. Giudice,et al.  Programmed cell death in human ovary is a function of follicle and corpus luteum status. , 1997, The Journal of clinical endocrinology and metabolism.

[79]  G. Hodgen,et al.  Folliculogenesis in the primate ovarian cycle. , 1981, Endocrine reviews.

[80]  K. Hirschi,et al.  Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. , 1999, Circulation research.

[81]  J. McCRACKEN,et al.  Luteolysis: a neuroendocrine-mediated event. , 1999, Physiological reviews.

[82]  Dendra M. Hillier,et al.  Paracrine Control of Follicular Estrogen Synthesis , 1991 .

[83]  James B. Brown,et al.  Pituitary Control of Ovarian Function — Concepts Derived from Gonadotrophin Therapy , 1978, The Australian & New Zealand journal of obstetrics & gynaecology.

[84]  S. Huang,et al.  Application of immunofluorescent staining on paraffin sections improved by trypsin digestion. , 1976, Laboratory investigation; a journal of technical methods and pathology.

[85]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[86]  D. Darland,et al.  Blood vessel maturation: vascular development comes of age. , 1999, The Journal of clinical investigation.

[87]  S. Hillier,et al.  Cell-specific expression of aromatase and LH receptor mRNAs in rat ovary. , 1992, Journal of molecular endocrinology.

[88]  R. Stouffer,et al.  Expression of matrix metalloproteinases and their tissue inhibitor messenger ribonucleic acids in macaque periovulatory granulosa cells: time course and steroid regulation. , 1999, Biology of reproduction.

[89]  Yasuhiko Hayashi,et al.  Possible Participation of Autocrine and Paracrine Vascular Endothelial Growth Factors in Hypoxia-induced Proliferation of Endothelial Cells and Pericytes (*) , 1995, The Journal of Biological Chemistry.

[90]  D. Redmer,et al.  Angiogenic activity of bovine corpora lutea at several stages of luteal development. , 1988, Journal of reproduction and fertility.

[91]  J. Mcgadey A tetrazolium method for non-specific alkaline phosphatase , 2004, Histochemie.

[92]  A. Schor,et al.  Tumour angiogenesis , 1983, The Journal of pathology.

[93]  R. Bicknell Endothelial cell culture: Introduction to the endothelial cell , 1996 .

[94]  R. Boulton,et al.  Assessing cell proliferation: a methodological review. , 1995, Clinical science.

[95]  N. Chegini,et al.  Quantitative cell composition of human and bovine corpora lutea from various reproductive states. , 1991, Biology of reproduction.

[96]  A. R. Midgley,et al.  Granulosa cell maturation in the rat: increased binding of human chorionic gonadotropin following treatment with follicle-stimulating hormone in vivo. , 1974, Endocrinology.

[97]  L. Hamberger,et al.  The Role of Prostaglandins and Catecholamines for Human Corpus Luteum Function , 1987 .

[98]  J. Richards Hormonal control of gene expression in the ovary. , 1994, Endocrine reviews.

[99]  H. Phillips,et al.  Vascular endothelial growth factor is expressed in rat corpus luteum. , 1990, Endocrinology.

[100]  H. Fraser,et al.  Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin. , 1987, Endocrinology.

[101]  The Role of Lipoproteins in the Regulation of Progesterone Secretion by the Human Corpus Luteum , 1982, Fertility and sterility.

[102]  David F. Albertini,et al.  THE APPEARANCE AND STRUCTURE OF INTERCELLULAR CONNECTIONS DURING THE ONTOGENY OF THE RABBIT OVARIAN FOLLICLE WITH PARTICULAR REFERENCE TO GAP JUNCTIONS , 1974, The Journal of cell biology.

[103]  J. Kerr,et al.  Patterns of cell death. , 1988, Methods and achievements in experimental pathology.

[104]  H. Fraser,et al.  Induced luteal regression in the primate: evidence for apoptosis and changes in c-myc protein. , 1995, The Journal of endocrinology.

[105]  S. Killilea,et al.  Production of mitogenic factor(s) by ovine corpora lutea throughout the estrous cycle. , 1992, Endocrinology.

[106]  A. Cummings,et al.  Differentiation of the uterus in preparation for gestation: a model for the action of progesterone. , 1984, Journal of theoretical biology.

[107]  A. Zeleznik Premature elevation of systemic estradiol reduces serum levels of follicle-stimulating hormone and lengthens the follicular phase of the menstrual cycle in rhesus monkeys. , 1981, Endocrinology.

[108]  K. Hirschi,et al.  Pericytes in the microvasculature. , 1996, Cardiovascular research.

[109]  J. Tilly,et al.  Gonadotropin-induced up- and down-regulation of ovarian follicle-stimulating hormone (FSH) receptor gene expression in immature rats: effects of pregnant mare's serum gonadotropin, human chorionic gonadotropin, and recombinant FSH. , 1992, Endocrinology.

[110]  M. Ferin,et al.  Mechanisms regulating the menstrual cycle in women. , 1970, Recent progress in hormone research.

[111]  A. Ferenczy,et al.  Proliferation kinetics of human endometrium during the normal menstrual cycle. , 1979, American journal of obstetrics and gynecology.

[112]  E. Adashi,et al.  Insulin‐like Growth Factor I as an Intraovarian Regulator: Basic and Clinical Implications a , 1991, Annals of the New York Academy of Sciences.

[113]  G. Niswender,et al.  Blood flow: a mediator of ovarian function. , 1976, Biology of reproduction.

[114]  R. Koos Stimulation of endothelial cell proliferation by rat granulosa cell-conditioned medium. , 1986, Endocrinology.

[115]  M. Sholley,et al.  Endothelial mitosis during the initial stages of corpus luteum neovascularization in the cycling adult rat. , 1985, The American journal of anatomy.

[116]  H. Fraser,et al.  The effect of the angiogenesis inhibitor TNP-470 on luteal establishment and function in the primate. , 1999, Human reproduction.

[117]  W. Hansel,et al.  Corpus luteum function in the alpaca. , 1970, Biology of reproduction.

[118]  L. Speroff,et al.  ESTROGEN-INDUCED HUMAN LUTEOLYSIS , 1973 .

[119]  H. Dvorak,et al.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.

[120]  A. Dharmarajan,et al.  Quantitative ultrastructural characteristics relating to transport between luteal cell cytoplasm and blood in the corpus luteum of the pregnant rat. , 1985, The American journal of anatomy.

[121]  K. Alitalo,et al.  VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. , 1996, Development.

[122]  G. Niswender,et al.  Nuclear changes in ovine luteal cells in response to PGF2 alpha. , 1990, Domestic animal endocrinology.

[123]  D. Baird,et al.  Changes in the binding of human chorionic gonadotrophin/luteinizing hormone, follicle-stimulating hormone and prolactin to human corpora lutea during the menstrual cycle and pregnancy. , 1980, The Journal of endocrinology.

[124]  M. Klagsbrun,et al.  Vascular endothelial growth factor and its receptors. , 1996, Cytokine & growth factor reviews.

[125]  U. Modlich,et al.  Ovarian angiogenesis. Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression. , 1995, The American journal of pathology.

[126]  C. Channing Influences of the in vivo and in vitro hormonal environment upon luteinization of granulosa cells in tissue culture. , 1970, Recent progress in hormone research.

[127]  G. Garcı́a-Cardeña,et al.  Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[128]  D. Baird,et al.  PHARMACOLOGICAL‘RESCUE’OF THE CORPUS LUTEUM RESULTS IN INCREASED INHIBIN PRODUCTION , 1990, Clinical endocrinology.

[129]  B. Charbonnel,et al.  Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration. , 1991, Fertility and sterility.

[130]  S. Liu,et al.  Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. , 1993, The American journal of physiology.

[131]  H. R. Lindner,et al.  Distribution of binding sites for human chorionic gonadotropin in the preovulatory follicle of the rat , 1975, The Journal of cell biology.

[132]  J. Strauss,et al.  Progesterone synthesis by luteinized human granulosa cells in culture: the role of de novo sterol synthesis and lipoprotein-carried sterol. , 1982, The Journal of clinical endocrinology and metabolism.

[133]  A. Zeleznik,et al.  The Rhesus Monkey Corpus Luteum Is Dependent on Pituitary Gonadotropin Secretion throughout the Luteal Phase of the Menstrual Cycle , 1984 .

[134]  M. J. Koering Cyclic changes in ovarian morphology during the menstrual cycle in Macaca mulatta. , 1969, The American journal of anatomy.

[135]  C. Belfiore,et al.  Steroidogenic enzyme activity after acute activation of protein kinase (PK) A and PKC in ovine small and large luteal cells , 1993, Molecular and Cellular Endocrinology.

[136]  L. Orci,et al.  Alpha-smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[137]  A. Rogol,et al.  Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. , 1995, Science.

[138]  L. Wildt,et al.  Pregnancies following chronic intermittent (pulsatile) administration of Gn-RH by means of a portable pump ("Zyklomat")--a new approach to the treatment of infertility in hypothalamic amenorrhea. , 1980, The Journal of clinical endocrinology and metabolism.

[139]  P. Rogers,et al.  Endometrial microvascular growth in normal and dysfunctional states. , 1998, Human reproduction update.

[140]  D. Haisenleder,et al.  Gonadotropin-releasing hormone pulses: regulators of gonadotropin synthesis and ovulatory cycles. , 1991, Recent progress in hormone research.

[141]  Mihaela Skobe,et al.  Halting angiogenesis suppresses carcinoma cell invasion , 1997, Nature Medicine.

[142]  R. Engerman,et al.  Cell turnover of capillaries. , 1967, Laboratory investigation; a journal of technical methods and pathology.

[143]  D. Ingber,et al.  Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth , 1990, Nature.

[144]  H. Augustin,et al.  Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[145]  J. Davies,et al.  The vascular system of the rabbit ovary and its relationship to ovulation , 1951, The Anatomical record.

[146]  P. Einat,et al.  Translation of Vascular Endothelial Growth Factor mRNA by Internal Ribosome Entry: Implications for Translation under Hypoxia , 1998, Molecular and Cellular Biology.

[147]  W. C. Duncan,et al.  The human corpus luteum: reduction in macrophages during simulated maternal recognition of pregnancy. , 1998, Human reproduction.

[148]  E. Keshet,et al.  A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. , 1998, Development.

[149]  A. L. Goodman,et al.  The ovarian triad of the primate menstrual cycle. , 1983, Recent progress in hormone research.

[150]  B. Burnside,et al.  Actin filaments in retinal pericytes and endothelial cells. , 1980, Investigative ophthalmology & visual science.

[151]  R. Stouffer,et al.  Vascular endothelial growth factor (VEGF) and angiopoietin regulation by gonadotrophin and steroids in macaque granulosa cells during the peri-ovulatory interval. , 1999, Molecular human reproduction.

[152]  C. Channing,et al.  Fine structural events correlated with progestin secretion during luteinization of rhesus monkey granulosa cells in culture. , 1972, Biology of reproduction.

[153]  Y. Hirata,et al.  Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. , 1997, Genomics.

[154]  C. Hartman,et al.  Removal of the corpus luteum and of the ovaries of the rhesus monkey during pregnancy: Observations and cautions , 1947, The Anatomical record.

[155]  J. Hearn,et al.  Changing responsiveness of luteal cells of the marmoset monkey (Callithrix jacchus) to luteotrophic and luteolytic agents during normal and conception cycles. , 1989, Journal of reproduction and fertility.

[156]  R. Kendall,et al.  Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[157]  E. Reed,et al.  The Pharmacokinetics of TNP‐470, a New Angiogenesis Inhibitor , 1997, Pharmacotherapy.

[158]  D. Wolf,et al.  Administration of human luteinizing hormone (hLH) to macaques after follicular development: further titration of LH surge requirements for ovulatory changes in primate follicles. , 1992, The Journal of clinical endocrinology and metabolism.

[159]  Thomas N. Sato,et al.  Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. , 1997, Science.

[160]  H. Dvorak,et al.  Secretion of vascular endothelial growth factor/vascular permeability factor from human luteinized granulosa cells is human chorionic gonadotrophin dependent. , 1998, Molecular human reproduction.

[161]  J. Hearn,et al.  Size distribution of luteal cells from pregnant and non-pregnant marmoset monkeys and a comparison of the morphology of marmoset luteal cells with those from the human corpus luteum. , 1990, Journal of reproduction and fertility.

[162]  Yvi J. Lebeux,et al.  Actin‐ and myosin‐like filaments in rat brain pericytes , 1978, The Anatomical record.

[163]  S. Lightman,et al.  Induction of luteal regression in the marmoset monkey (Callithrix jacchus) by a gonadotrophin-releasing hormone antagonist and the effects on subsequent follicular development. , 1988, Journal of reproduction and fertility.

[164]  H. Dvorak,et al.  Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. , 1997, EXS.

[165]  L. Orci,et al.  Basic fibroblast growth factor induces angiogenesis in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[166]  R. Stouffer,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Follicle-Stimulating Hormone and Luteinizing Hormone/ Chorionic Gonadotropin Stimulation of Vascular Endothelial Growth Factor Production by Macaq , 2022 .

[167]  H. Behrman,et al.  Oxygen Radicals and Reactive Oxygen Species in Reproduction , 1991, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[168]  J. Finlayson,et al.  Regulation of fibronectin and laminin synthesis by retinal capillary endothelial cells and pericytes in vitro. , 1993, Experimental eye research.

[169]  Lars Holmgren,et al.  Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.

[170]  H. Yamamoto,et al.  Vascular pericytes not only regulate growth, but also preserve prostacyclin-producing ability and protect against lipid peroxide-induced injury of co-cultured endothelial cells. , 1993, Biochemical and biophysical research communications.

[171]  R. Ohlsson,et al.  Angiogenesis during human extraembryonic development involves the spatiotemporal control of PDGF ligand and receptor gene expression. , 1991, Development.

[172]  A. Gougeon Regulation of ovarian follicular development in primates: facts and hypotheses. , 1996, Endocrine reviews.

[173]  A. Miyamoto,et al.  Real-time relationships between intraluteal and plasma concentrations of endothelin, oxytocin, and progesterone during prostaglandin F2alpha-induced luteolysis in the cow. , 1998, Biology of reproduction.

[174]  C. Verschraegen,et al.  A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[175]  W. Pardridge,et al.  Differential expression of alpha-actin mRNA and immunoreactive protein in brain microvascular pericytes and smooth muscle cells. , 1994, Journal of neuroscience research.

[176]  E. Manseau,et al.  Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. , 1995, American Journal of Pathology.

[177]  Bing Li,et al.  Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo , 1993, Nature.

[178]  J. Williams,et al.  Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth. , 1985, The American journal of pathology.

[179]  N. Yamanaka,et al.  Neovascularization of the corpus luteum of rats during the estrus cycle , 1996, Pathology international.

[180]  G. Webley,et al.  Roles of cyclic AMP and inositol phosphates in the luteolytic action of cloprostenol, a prostaglandin F2 alpha analogue, in marmoset monkeys (Callithrix jacchus). , 1993, Journal of reproduction and fertility.

[181]  S. Wiegand,et al.  Luteal angiogenesis: prevention and intervention by treatment with vascular endothelial growth factor trap(A40). , 2001, The Journal of clinical endocrinology and metabolism.

[182]  S. Shapiro,et al.  Progesterone-altered secretory proteins from cultured human endometrium. , 1983, Endocrinology.

[183]  H. Fraser,et al.  Insulin-like growth factor binding protein-3 mRNA expression in endothelial cells of the primate corpus luteum. , 1998, Human reproduction.

[184]  H. Phillips,et al.  Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary. , 1992, Endocrinology.

[185]  G. Rune,et al.  Oxytocin gene expression and oxytocin immunoactivity in the ovary of the common marmoset monkey (Callithrix jacchus). , 1994, Biology of reproduction.

[186]  L Piana,et al.  CD31 quantitative immunocytochemical assays in breast carcinomas. Correlation with current prognostic factors. , 1995, American journal of clinical pathology.

[187]  M. Breckwoldt,et al.  Vascular endothelial growth factor (VEGF) messenger ribonucleic acid (mRNA) expression in luteinized human granulosa cells in vitro. , 1993, The Journal of clinical endocrinology and metabolism.

[188]  Kenneth J. Hillan,et al.  Vascular endothelial growth factor is essential for corpus luteum angiogenesis , 1998, Nature Medicine.

[189]  R. Stouffer,et al.  Proliferation of microvascular endothelial cells in the primate corpus luteum during the menstrual cycle and simulated early pregnancy. , 1996, Endocrinology.

[190]  D. Redmer,et al.  Angiogenesis in the corpus luteum , 2000, Endocrine.

[191]  D. Gospodarowicz,et al.  Production a corpus luteum angiogenic factor responsible for proliferation of capillaries and neovascularization of the corpus luteum. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[192]  D. Baird,et al.  Relationship between the secretion of the corpus luteum and the length of the follicular phase of the ovarian cycle. , 1975, Journal of reproduction and fertility.

[193]  D. Redmer,et al.  Cellular Interactions in the Corpus Luteum , 1997, Seminars in reproductive endocrinology.

[194]  R. Ansbacher,et al.  Decidual prolactin production by organ cultures of human endometrium: effects of continuous and intermittent progesterone treatment. , 1986, Biology of reproduction.

[195]  A. Hertig,et al.  Studies on the human corpus luteum. I. Observations on the ultrastructure of development and regression of the luteal cells during the menstrual cycle. , 1969, The Journal of cell biology.

[196]  J. V. Von Roenn,et al.  Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[197]  J. Folkman,et al.  Blood Vessel Formation: What Is Its Molecular Basis? , 1996, Cell.

[198]  D E Ingber,et al.  Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix , 1989, The Journal of cell biology.

[199]  H. Fraser,et al.  Induced luteolysis in the primate: rapid loss of luteinizing hormone receptors. , 1998, Human reproduction.

[200]  H. Spies,et al.  Changing frequency of pulsatile luteinizing hormone and progesterone secretion during the luteal phase of the menstrual cycle of rhesus monkeys. , 1984, Biology of reproduction.

[201]  G. de Sousa,et al.  Interspecies variability of TNP-470 metabolism, using primary monkey, rat, and dog cultured hepatocytes. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[202]  R. Greep,et al.  Effect of HCG antiserum on ovulation and corpus luteum formation in the monkey (Macaca fascicularis). , 1971, The Journal of clinical endocrinology and metabolism.

[203]  D E Ingber,et al.  Fibronectin controls capillary endothelial cell growth by modulating cell shape. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[204]  H. Fraser,et al.  Inhibin secretion during the ovulatory cycle and pregnancy in the common marmoset monkey. , 1990, The Journal of endocrinology.

[205]  D. Tenen,et al.  Molecular cloning of a cDNA encoding CD34, a sialomucin of human hematopoietic stem cells. , 1992, Journal of immunology.

[206]  D. Robertson,et al.  Plasma inhibin levels during gonadotropin‐induced ovarian hyperstimulation for IVF: A new index of follicular function? , 1987 .

[207]  Urban Deutsch,et al.  Angiopoietin-1 induces sprouting angiogenesis in vitro , 1998, Current Biology.

[208]  P. Bohlen,et al.  Corpus luteum angiogenic factor is related to fibroblast growth factor. , 1985, Endocrinology.

[209]  W. Risau Embryonic angiogenesis factors. , 1991, Pharmacology & therapeutics.

[210]  I. Rothchild The regulation of the mammalian corpus luteum. , 1981, Recent progress in hormone research.

[211]  R. Nakano,et al.  The vascular endothelial growth factor/fms-like tyrosine kinase system in human ovary during the menstrual cycle and early pregnancy. , 1999, The Journal of clinical endocrinology and metabolism.

[212]  G. T. Moore,et al.  Ovarian function of hysterectomized Macaca fascicularis. , 1979, Biology of reproduction.

[213]  C. Zaloudek,et al.  Vascular endothelial growth factor localization in human ovary and fallopian tubes: possible role in reproductive function and ovarian cyst formation. , 1996, The Journal of clinical endocrinology and metabolism.

[214]  T. Fan,et al.  Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. , 1995, Trends in pharmacological sciences.

[215]  S. Pories,et al.  An intra-corpus luteum site for the luteolytic action of prostaglandin F2α in the rhesus monkey , 1984 .

[216]  B. Murphy,et al.  Steroidogenic acute regulatory protein in bovine corpora lutea. , 1996, Biology of reproduction.

[217]  R. Miller,et al.  The structure and specificity of endothelin receptors: their importance in physiology and medicine. , 1993, Pharmacology & therapeutics.

[218]  D. Torry,et al.  Angiogenesis and the Expression of Vascular Endothelial Growth Factor in Endometrium and Placenta , 1997, American journal of reproductive immunology.

[219]  Shay Soker,et al.  Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor , 1998, Cell.

[220]  W. Thompson,et al.  The clinical manipulation of angiogenesis: pathology, side‐effects, surprises, and opportunities with novel human therapies , 1999, The Journal of pathology.

[221]  H. Fraser,et al.  Endothelial cell proliferation follows the mid-cycle luteinizing hormone surge, but not human chorionic gonadotrophin rescue, in the human corpus luteum. , 1997, Human reproduction.

[222]  H. McClure,et al.  Pharmacokinetics and metabolism of O-(chloroacetyl-carbamoyl) fumagillol (TNP-470, AGM-1470) in rhesus monkeys , 1996, Cancer Chemotherapy and Pharmacology.

[223]  P. Nelson,et al.  Effects of different gonadotropin pulse frequencies on corpus luteum function during the menstrual cycle of rhesus monkeys. , 1986, Endocrinology.

[224]  A. Csapo,et al.  Effects of luteectomy and progesterone replacement therapy in early pregnant patients. , 1973, American journal of obstetrics and gynecology.

[225]  D. L. Bassett The changes in the vascular pattern of the ovary of the albino rat during the estrous cycle , 1943 .

[226]  K. Alitalo,et al.  A novel vascular endothelial growth factor, VEGF‐C, is a ligand for the Flt4 (VEGFR‐3) and KDR (VEGFR‐2) receptor tyrosine kinases. , 1996, The EMBO journal.

[227]  S. Kholkute Plasma progesterone levels throughout the ovarian cycle of the common marmoset (Callithrix jacchus) , 2006, Primates.

[228]  Azmi Ti,et al.  Mechanism of deletion of endothelial cells during regression of the corpus luteum. , 1984, Laboratory investigation; a journal of technical methods and pathology.

[229]  G. Erickson Defining Apoptosis: Players and Systems , 1997, The Journal of the Society for Gynecologic Investigation: JSGI.

[230]  R. Abdul-Karim,et al.  Blood flow to the ovary and corpus luteum at different stages of gestation in the rabbit. , 1973, Fertility and sterility.

[231]  S. Hillier,et al.  Control of preovulatory follicular estrogen biosynthesis in the human ovary. , 1981, The Journal of clinical endocrinology and metabolism.

[232]  D. Redmer,et al.  Expression of the angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor, in the ovary. , 1998, Journal of animal science.

[233]  J. D. Neill,et al.  Failure of hysterectomy to influence the normal pattern of cyclic progesterone secretion in the rhesus monkey. , 1969, Endocrinology.

[234]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[235]  H. Fraser,et al.  Cell proliferation and vascular morphology in the marmoset corpus luteum. , 2000, Human reproduction.

[236]  P. Jones,et al.  Prostaglandin F2α activates protein kinase C in human ovarian cells , 1993, Molecular and Cellular Endocrinology.

[237]  C. Reymundo,et al.  Macrophages, cell proliferation, and cell death in the human menstrual corpus luteum. , 1998, Biology of reproduction.

[238]  Janet Rossant,et al.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.

[239]  A. Flint,et al.  Mechanisms controlling corpus luteum function in sheep, cows, nonhuman primates, and women especially in relation to the time of luteolysis. , 1988, Endocrine reviews.

[240]  Hiroshi Yamamoto,et al.  Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditions. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[241]  M. Brown,et al.  A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.

[242]  E. Block Quantitative morphological investigations of the follicular system in women; variations in the different phases of the sexual cycle. , 1951, Acta endocrinologica.

[243]  K. Alitalo,et al.  Genomic Organization of the Mouse and Human Genes for Vascular Endothelial Growth Factor B (VEGF-B) and Characterization of a Second Splice Isoform* , 1996, The Journal of Biological Chemistry.

[244]  A. Mcneilly,et al.  Effects of an LH-releasing hormone antagonist on the secretion of LH, FSH, prolactin and ovarian steroids at different stages of the luteal phase in the stumptailed macaque (Macaca arctoides). , 1986, Journal of Endocrinology.

[245]  D. D. Bois,et al.  A height-weight formula to estimate the surface area of man , 1916 .

[246]  J. Martial,et al.  The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. , 1993, Endocrinology.

[247]  R. Koistinen,et al.  Insulin-like growth factor-I (IGF-I) inhibits production of IGF-binding protein-1 while stimulating estradiol secretion in granulosa cells from normal and polycystic human ovaries. , 1993, The Journal of clinical endocrinology and metabolism.

[248]  M. Klagsbrun,et al.  Regulators of angiogenesis. , 1991, Annual review of physiology.

[249]  J. Folkman,et al.  Analysis of experimental antiangiogenic therapy. , 1993, Journal of pediatric surgery.

[250]  S. Akiba,et al.  Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma , 1996, Cancer.

[251]  J. Carlson,et al.  Oxygen radicals and the control of ovarian corpus luteum function. , 1993, Free radical biology & medicine.

[252]  A. Jablonka-Shariff,et al.  Growth and cellular proliferation of ovine corpora lutea throughout the estrous cycle. , 1993, Endocrinology.

[253]  V Nehls,et al.  Heterogeneity of microvascular pericytes for smooth muscle type alpha- actin , 1991, The Journal of cell biology.

[254]  P. Fricke,et al.  Evaluation of growth, cell proliferation, and cell death in bovine corpora lutea throughout the estrous cycle. , 1994, Biology of reproduction.

[255]  J. Folkman,et al.  The sequence of events in the regression of corneal capillaries. , 1978, Laboratory investigation; a journal of technical methods and pathology.

[256]  J. Isner,et al.  Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. , 1998, Circulation research.

[257]  R. D'Amato,et al.  Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470 , 1997, Nature Medicine.

[258]  J. Hodges,et al.  Cloprostenol-induced luteolysis in the marmoset monkey (Callithrix jacchus). , 1985, Journal of reproduction and fertility.

[259]  W L Miller,et al.  Molecular biology of steroid hormone synthesis. , 1988, Endocrine reviews.

[260]  H. Fraser,et al.  Printed in U.S.A. Copyright © 2000 by The Endocrine Society Suppression of Luteal Angiogenesis in the Primate after Neutralization of Vascular Endothelial Growth Factor* , 2022 .

[261]  S. Hillier,et al.  Follicular oestrogen synthesis: the ‘two-cell, two-gonadotrophin’ model revisited , 1994, Molecular and Cellular Endocrinology.

[262]  J. Rhodin,et al.  Capillary growth in the mesentery of normal young rats. Intravital video and electron microscope analyses. , 1989, Journal of submicroscopic cytology and pathology.

[263]  P. Wright,et al.  Cellular composition of the sheep corpus luteum in the mid- and late luteal phases of the oestrous cycle. , 1986, Journal of reproduction and fertility.

[264]  C. Ferrell Placental Regulation of Fetal Growth , 1989 .

[265]  Growth factor effects on cells of the vascular wall: a survey. , 1993, Growth factors.

[266]  A. Zeleznik,et al.  Expression of messenger ribonucleic acids that encode for 3 beta-hydroxysteroid dehydrogenase and cholesterol side-chain cleavage enzyme throughout the luteal phase of the macaque menstrual cycle. , 1991, The Journal of clinical endocrinology and metabolism.

[267]  B. Fisch,et al.  Cellular basis of luteal steroidogenesis in the human ovary. , 1989, The Journal of endocrinology.

[268]  D. Baird,et al.  Effect of enucleation of the corpus luteum at different stages of the luteal phase of the human menstrual cycle on subsequent follicular development. , 1984, Journal of reproduction and fertility.

[269]  R. Greep,et al.  Production of ovulation in the hypophysectomized rhesus monkey. , 1960, Endocrinology.

[270]  L. Wildt,et al.  Control of the rhesus monkey menstrual cycle: permissive role of hypothalamic gonadotropin-releasing hormone , 1980, Science.

[271]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[272]  T. Jacks,et al.  Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[273]  D. Redmer,et al.  Utero-placental vascular development and placental function. , 1995, Journal of animal science.

[274]  R. Nakano,et al.  Apoptosis of human corpora lutea during cyclic luteal regression and early pregnancy. , 1996, The Journal of clinical endocrinology and metabolism.

[275]  J. Hearn Reproduction in new world primates : new models in medical science , 1983 .

[276]  D. Abbott,et al.  Morphological changes of the ovary and hormonal changes through the ovarian cycle of the common marmoset (Callithrix jacchus) , 1996, Primates.

[277]  W. Gradishar Endpoints for Determination of Efficacy of Antiangiogenic Agents in Clinical Trials , 1999 .

[278]  H Stein,et al.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. , 1984, Journal of immunology.

[279]  H. Fraser,et al.  Cell death during luteal regression in the marmoset monkey (Callithrix jacchus). , 1997, Journal of reproduction and fertility.

[280]  M. F. Smith,et al.  Effect of prostaglandin F2 alpha on the adenylate cyclase and phosphodiesterase activity of ovine corpora lutea. , 1984, Journal of animal science.

[281]  E. Adashi,et al.  Ovarian follicular atresia as an apoptotic process: A paradigm for programmed cell death in endocrine tissues , 1992, Molecular and Cellular Endocrinology.